Tessera Stock
HealthTechLooking to sell Tessera stock or options?
Tessera, a pioneer in gene writing technology, is designed to facilitate both minor and major modifications to the human genome. This innovative technology serves as a powerful tool for scientists and clinicians to inscribe therapeutic messages, both small and large, into the genome to address diseases at their origin. Consequently, it empowers healthcare providers to treat their patients effectively, thereby enhancing their quality of life.
Abu Dhabi Investment Authority, Toba Capital, Bill & Melinda Gates Foundation, JUMP Investors, Shake and Bake, Flagship Pioneering, T. Rowe Price Group, TA Ventures, Catalio Capital Management, Alaska Permanent Fund, Qatar Investment Authority, March Capital, OMX Ventures, Altitude Life Science Ventures, SoftBank Investment Advisers, Salt Funds Management, Berkeley, Longevity Vision Fund, University of California, Hanwha Impact, EDBI, Cormorant Asset Management, ARTIS Ventures, Foresite Capital.